eMyoSound is developing an innovative medical device for diagnosing heart failure. This innovation is based on a breakthrough technology that uses ultrasound to palpate the heart and quantify cardiac rigidity using an analysis based on artificial intelligence. eMyoSound's ambition is to become the leader in non-invasive heart failure diagnosis by marketing an innovative ultrasound system to cardiologists worldwide.
Medical devices, Ultrasound
Strategic business lines
Electronics : materials, components and subsystems
Accession on09 / 02 / 2024
Structure
Company4 Employees
Contact informations
eMyosound
30 rue André Theuriet
Tours,